This is a very good question, there is little data on this and there are only a few case series. One case series of 8 patients showed a 25% risk of recurrence in one year with May-Thurner syndrome but too small of a sample to really know what the risk is, plus this probably included a heterogenous m...

This clinical scenario should also include two other relevant questions: what is the etiology of DVT and what kind of antithrombotic therapy and duration will be necessary after venous stent placement? Because the optimal anticoagulation regimen and duration for each etiology may be different. If DV...

Anecdotally, we have had 3 patients in our institution who underwent stenting of the left common iliac vessel without recurrence of the thrombosis after 3-6 months of anticoagulation. All are three years out or more since presentation with unprovoked, symptomatic, LLE thrombosis. 

I looked at the literature as I was planning the treatment of a child (pre-teen) with MTS due to horseshoe kidney. Due to high risk of recurrence (Avila et al., PMID 33651481), we planned to continue treatment until growth stops/slows (mid-adolescence) then place a stent, continue anticoagulation fo...